This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
covid-19 | patients | 180 |
ill | patients | 150 |
pediatric | patients | 124 |
- | hospital | 119 |
high | risk | 110 |
medical | patients | 109 |
mean | age | 106 |
- | dose | 94 |
median | age | 79 |
- | risk | 77 |
- | cell | 67 |
- | analysis | 62 |
retrospective | study | 43 |
higher | risk | 39 |
- | cells | 39 |
primary | outcome | 34 |
patient | care | 33 |
- | time | 32 |
clinical | outcomes | 32 |
covid-19 | infection | 31 |
low | risk | 31 |
median | time | 29 |
- | year | 27 |
patients | aged | 27 |
retrospective | analysis | 26 |
- | care | 26 |
severe | covid-19 | 24 |
high | dose | 23 |
clinical | data | 23 |
patient | outcomes | 22 |
- | level | 21 |
severe | disease | 20 |
primary | care | 18 |
older | age | 17 |
pediatric | patient | 17 |
first | case | 16 |
medical | treatment | 16 |
high | rate | 14 |
higher | rates | 14 |
high | rates | 14 |
- | vte | 14 |
high | levels | 14 |
clinical | outcome | 14 |
higher | rate | 13 |
significant | risk | 13 |
patients | using | 12 |
respiratory | infection | 12 |
primary | diagnosis | 12 |
acute | vte | 12 |
high | vte | 12 |
acute | infection | 12 |
- | therapy | 12 |
- | treatment | 11 |
lower | risk | 11 |
medical | care | 11 |
other | patients | 11 |
low | dose | 10 |
positive | patients | 10 |
respiratory | rate | 10 |
highest | risk | 10 |
higher | doses | 10 |
first | year | 10 |
acute | care | 9 |
clinical | care | 9 |
low | levels | 9 |
older | patients | 9 |
patient | days | 9 |
such | patients | 9 |
mean | time | 8 |
severe | cases | 8 |
pulmonary | disease | 8 |
patient | data | 8 |
other | studies | 8 |
covid-19 | patient | 8 |
ill | patient | 8 |
clinical | study | 8 |
- | patients | 8 |
- | patient | 8 |
higher | dose | 7 |
retrospective | case | 7 |
primary | outcomes | 7 |
medical | therapy | 7 |
initial | treatment | 7 |
early | studies | 7 |
acute | infections | 7 |
- | years | 7 |
- | group | 7 |
- | day | 7 |
initial | therapy | 6 |
retrospective | data | 6 |
primary | diagnoses | 6 |
patient | age | 6 |
other | risk | 6 |
median | dose | 6 |
clinical | studies | 6 |
initial | diagnosis | 6 |
first | patient | 6 |
early | use | 6 |
- | study | 6 |
first | study | 6 |
other | factors | 5 |
respiratory | disease | 5 |
primary | disease | 5 |
positive | cells | 5 |
pediatric | cases | 5 |
patients | ages | 5 |
positive | results | 5 |
medical | patient | 5 |
lower | rates | 5 |
early | diagnosis | 5 |
clinical | factors | 5 |
- | analyses | 5 |
mean | hospital | 5 |
other | treatment | 4 |
low | rates | 4 |
lower | rate | 4 |
other | patient | 4 |
other | study | 4 |
patients | age | 4 |
patient | groups | 4 |
patient | outcome | 4 |
post | treatment | 4 |
such | cases | 4 |
initial | studies | 4 |
low | level | 4 |
severe | infections | 4 |
higher | levels | 4 |
covid-19 | cases | 4 |
higher | level | 4 |
- | times | 4 |
clinical | diagnosis | 4 |
common | diagnosis | 4 |
clinical | use | 4 |
early | outcomes | 4 |
first | day | 4 |
first | dose | 4 |
high | doses | 4 |
high | level | 4 |
mean | ages | 3 |
pediatric | hospital | 3 |
other | groups | 3 |
other | disease | 3 |
other | day | 3 |
other | cases | 3 |
median | hospital | 3 |
severe | risk | 3 |
low | rate | 3 |
first | time | 3 |
first | patients | 3 |
common | risk | 3 |
- | outcomes | 3 |
- | age | 3 |
highest | rates | 3 |
patient | group | 2 |
positive | outcomes | 2 |
positive | covid-19 | 2 |
pediatric | data | 2 |
patients | result | 2 |
other | diseases | 2 |
patient | factors | 2 |
patient | ages | 2 |
positive | result | 2 |
other | vte | 2 |
other | therapy | 2 |
positive | rate | 2 |
primary | cells | 2 |
post | diagnosis | 2 |
primary | analysis | 2 |
respiratory | care | 2 |
respiratory | diseases | 2 |
respiratory | infections | 2 |
retrospective | studies | 2 |
severe | infection | 2 |
significant | disease | 2 |
significant | rates | 2 |
such | studies | 2 |
venous | diseases | 2 |
other | therapies | 2 |
medical | treatments | 2 |
old | patients | 2 |
early | treatment | 2 |
old | patient | 2 |
- | case | 2 |
- | days | 2 |
- | disease | 2 |
- | p | 2 |
- | use | 2 |
acute | treatment | 2 |
clinical | vte | 2 |
common | patient | 2 |
covid-19 | diagnosis | 2 |
- | factor | 2 |
early | vte | 2 |
lower | level | 2 |
non | vte | 2 |
higher | vte | 2 |
median | days | 2 |
lower | levels | 2 |
mean | treatment | 2 |
low | doses | 2 |
initial | results | 2 |
initial | patient | 2 |
initial | data | 2 |
patient | using | 1 |
patients | resulted | 1 |
patient | year | 1 |
patients | care | 1 |
patients | grouped | 1 |
patients | groups | 1 |
patients | rated | 1 |
patients | vte | 1 |
patients | results | 1 |
patients | risk | 1 |
patients | studied | 1 |
patients | used | 1 |
pediatric | case | 1 |
pediatric | diagnoses | 1 |
pediatric | vte | 1 |
patient | resulted | 1 |
patient | treatment | 1 |
other | cell | 1 |
patient | hospital | 1 |
other | diagnoses | 1 |
median | times | 1 |
medical | therapies | 1 |
non | covid-19 | 1 |
old | age | 1 |
older | studies | 1 |
positive | outcome | 1 |
other | group | 1 |
patient | factor | 1 |
other | hospitals | 1 |
other | p | 1 |
other | risks | 1 |
patient | cells | 1 |
patient | diagnosis | 1 |
patient | disease | 1 |
positive | disease | 1 |
pulmonary | infection | 1 |
positive | patient | 1 |
positive | using | 1 |
significant | infections | 1 |
significant | levels | 1 |
significant | result | 1 |
significant | time | 1 |
significant | treatment | 1 |
significant | vte | 1 |
significant | year | 1 |
such | case | 1 |
such | data | 1 |
such | disease | 1 |
such | factors | 1 |
such | results | 1 |
such | risk | 1 |
such | therapy | 1 |
such | treatment | 1 |
significant | factors | 1 |
significant | factor | 1 |
significant | age | 1 |
primary | vte | 1 |
post | therapy | 1 |
primary | data | 1 |
primary | infection | 1 |
primary | patient | 1 |
primary | patients | 1 |
primary | treatment | 1 |
pulmonary | factors | 1 |
severe | patients | 1 |
mean | vte | 1 |
respiratory | rates | 1 |
respiratory | therapy | 1 |
retrospective | analyses | 1 |
severe | case | 1 |
severe | groups | 1 |
median | rate | 1 |
initial | use | 1 |
mean | patient | 1 |
mean | levels | 1 |
common | cell | 1 |
common | diagnoses | 1 |
common | outcomes | 1 |
common | treatment | 1 |
covid-19 | diagnoses | 1 |
covid-19 | disease | 1 |
covid-19 | hospital | 1 |
covid-19 | infections | 1 |
covid-19 | rate | 1 |
covid-19 | therapies | 1 |
covid-19 | treatment | 1 |
covid-19 | using | 1 |
earlier | disease | 1 |
earlier | studies | 1 |
earlier | study | 1 |
common | age | 1 |
clinical | time | 1 |
clinical | therapies | 1 |
- | studied | 1 |
- | doses | 1 |
- | factors | 1 |
- | groups | 1 |
- | infection | 1 |
- | levels | 1 |
- | rated | 1 |
- | used | 1 |
clinical | risks | 1 |
- | using | 1 |
clinical | case | 1 |
clinical | cases | 1 |
clinical | patient | 1 |
clinical | results | 1 |
clinical | risk | 1 |
early | data | 1 |
early | group | 1 |
early | hospital | 1 |
low | patient | 1 |
initial | case | 1 |
initial | dose | 1 |
initial | infection | 1 |
initial | study | 1 |
initial | therapies | 1 |
initial | year | 1 |
low | use | 1 |
highest | rate | 1 |
lower | cell | 1 |
lower | groups | 1 |
lower | treatment | 1 |
lowest | risk | 1 |
mean | dose | 1 |
mean | dosing | 1 |
ill | covid-19 | 1 |
highest | level | 1 |
early | results | 1 |
first | therapy | 1 |
early | time | 1 |
first | analysis | 1 |
first | cases | 1 |
first | diagnosis | 1 |
first | level | 1 |
first | studies | 1 |
high | cells | 1 |
higher | use | 1 |
high | risks | 1 |
high | use | 1 |
higher | age | 1 |
higher | dosing | 1 |
higher | hospital | 1 |
higher | treatment | 1 |
venous | disease | 1 |